CENTENE CORPORATION |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 71.59 USD | +3.81% |
|
-4.07% | -3.53% |
| 31/05 | Stephens Adjusts Price Target on Centene to $77 From $83 | MT |
| 31/05 | Transcript : Centene Corporation Presents at Bernstein?s 40th Annual Strategic Decisions Conference, May-31-2024 08:00 AM |
| Sales 2024 * | 15TCr 12,45900Cr | Sales 2025 * | 15TCr 12,89600Cr | Capitalization | 3.82TCr 3,18700Cr |
|---|---|---|---|---|---|
| Net income 2024 * | 309.9Cr 26TCr | Net income 2025 * | 323.6Cr 27TCr | EV / Sales 2024 * | 0.27 x |
| Net Debt 2024 * | 240.99Cr 20TCr | Net cash position 2025 * | 100Cr 8.32TCr | EV / Sales 2025 * | 0.24 x |
| P/E ratio 2024 * |
12
x | P/E ratio 2025 * |
11
x | Employees | 67,700 |
| Yield 2024 * |
-
| Yield 2025 * |
2.33% | Free-Float | 86.31% |
More Fundamentals
* Assessed data
More news
Latest transcript on Centene Corporation
More recommendations
More press releases
More news
| 1 day | +3.81% | ||
| 1 week | -4.07% | ||
| 1 month | -2.01% | ||
| 3 months | -8.72% | ||
| 6 months | -2.84% | ||
| Current year | -3.53% |
1 week
66.79
74.58
1 month
66.7979.02
Current year
66.7981.42
1 year
60.8381.42
3 years
59.6798.53
5 years
41.6298.53
10 years
17.7498.53
| Managers | Title | Age | Since |
|---|---|---|---|
Sarah London
CEO | Chief Executive Officer | 43 | 01/20/01 |
Drew Asher
DFI | Director of Finance/CFO | 55 | 01/20/01 |
Kenneth Fasola
PSD | President | 64 | 06/22/06 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Monte Ford
BRD | Director/Board Member | 64 | 12/22/12 |
| Director/Board Member | 71 | 01/22/01 | |
| Chairman | 65 | 01/06/01 |
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 1.63% | 1,085 M€ | +9.05% | - | |
| 1.41% | 17 M€ | +6.09% | - | |
| 1.31% | 2 M€ | -.--% |
| Date | Price | Change | Volume |
|---|---|---|---|
| 31/24/31 | 71.59 | +3.81% | 7,385,022 |
| 30/24/30 | 68.96 | -2.18% | 6,598,041 |
| 29/24/29 | 70.5 | -3.05% | 6,691,494 |
| 28/24/28 | 72.72 | -2.56% | 4,039,136 |
| 24/24/24 | 74.63 | -3.49% | 4,019,964 |
Delayed Quote Nyse, May 01, 2024 at 01:35 am IST
More quotes
Centene Corporation specializes in health services. Revenues break down by activity as follows:
- development of health insurance programs (91%): primarily for children, pregnant women, blind and disabled persons;
- specialized services (9%): pharmaceutical services (claims processing, pharmacy network management, mail order sales, home delivery, analysis and clinical consulting services, etc.), health care services by education and empowerment (behavioral orientation programs and welfare, nursing advice, etc.), eye and dental care services, home care services, development of health care management solutions, etc.
Sector
Managed Healthcare
Calendar
26/07/2024
- Q2 2024 Earnings Release
Related indices
Trading Rating
Investor Rating
ESG Refinitiv
B-
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
20
Last Close Price
71.59
USD
Average target price
88.9
USD
Spread / Average Target
+24.19%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| -3.53% | 3.82TCr | |
| -5.91% | 46TCr | |
| +14.19% | 13TCr | |
| +15.08% | 9.79TCr | |
| -21.78% | 4.32TCr | |
| -12.93% | 1.84TCr | |
| -27.51% | 256.62Cr | |
| -8.59% | 150.47Cr |
- Stock Market
- Equities
- CNC Stock
